Vertex Pharmaceuticals Incorporated Company Information
Vertex Pharmaceuticals Incorporated's employee growth, exchange listings and data sources
Key Information
- Name: Vertex Pharmaceuticals Incorporated
- Ticker: VRTX
- Exchange: NasdaqGS
- Founded: 1989
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$102.309b
- Shares Outstanding: 257.53m
- Website: https://www.vrtx.com
Number of Employees
Location
- Vertex Pharmaceuticals Incorporated
- 50 Northern Avenue
- Boston
- Massachusetts
- 02210
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| VRTX | NasdaqGS (Nasdaq Global Select) | Yes | Common Shares | US | USD | Jul 1991 |
| VX1 | XTRA (XETRA Trading Platform) | Yes | Common Shares | DE | EUR | Jul 1991 |
| VX1 | DB (Deutsche Boerse AG) | Yes | Common Shares | DE | EUR | Jul 1991 |
| VRTX * | BMV (Bolsa Mexicana de Valores) | Yes | Common Shares | MX | MXN | Jul 1991 |
| 0QZU | LSE (London Stock Exchange) | Yes | Common Shares | GB | USD | Jul 1991 |
| VRTX | WBAG (Wiener Boerse AG) | Yes | Common Shares | AT | EUR | Jul 1991 |
| 4VRTX | ETLX (Eurotlx) | Yes | Common Shares | IT | EUR | Jul 1991 |
| VX1D | BATS-CHIXE (BATS 'Chi-X Europe') | Yes | Common Shares | GB | EUR | Jul 1991 |
| VRTX34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH 4 REP 1 COM USD0.01 | BR | BRL | May 2019 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:28 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:28 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Vertex Pharmaceuticals Incorporated is covered by 77 analysts. 33 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Brian Skorney | Baird |
| Ishan Majumdar | Baptista Research |